ALLISON WALLICK: Open Payments
NPI 1821592312 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 11 payments from 10 companies in 2025. Trend: 2023 $102 · 2024 $436 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| SANOFI PASTEUR INC. | 1 | $15 |
| Gilead Sciences, Inc. | 1 | $15 |
| GENZYME CORPORATION | 1 | $15 |
Products named: CAPLYTA, AUSTEDO XR, AIRSUPRA, Kerendia, VRAYLAR, HETLIOZ, REXULTI, BEYFORTUS.
Industry payments across NE — which companies pay providers there.
